120 related articles for article (PubMed ID: 8005816)
1. Metabolic studies and neurotoxicity in tumors and brain of mice after hypoxic cell sensitizers.
Streffer C; Tamulevicius P
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):571-5. PubMed ID: 8005816
[TBL] [Abstract][Full Text] [Related]
2. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
Murayama C; Mori T
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
[TBL] [Abstract][Full Text] [Related]
3. [Radiosensitizer: hypoxic cell radiosensitizer].
Mori T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M
Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329
[TBL] [Abstract][Full Text] [Related]
6. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
Sasai K; Nishimoto S; Shimokawa K; Hisanaga Y; Kitakabu Y; Shibamoto Y; Zhou L; Wang J; Takahashi M; Kagiya T
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
[TBL] [Abstract][Full Text] [Related]
8. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses.
Oya N; Shibamoto Y; Shibata T; Sasai K; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1153-9. PubMed ID: 7961025
[TBL] [Abstract][Full Text] [Related]
9. [Development of new hypoxic cell radiosensitizer in Japan].
Mori T; Murayama C
Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic transforming potential of nitroimidazole radiosensitizers.
Hall EJ; Hei TK
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1231-4. PubMed ID: 2523882
[TBL] [Abstract][Full Text] [Related]
11. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409
[TBL] [Abstract][Full Text] [Related]
12. Fluorine modification of nitroazole radiosensitizers for the enhancement of sensitizing activity with lowering toxicity: a pharmacokinetic characterization.
Kagiya VT; Nishimoto S; Ito T; Wang J; Abe M; Sasai K
Int J Radiat Oncol Biol Phys; 1992; 22(3):601-5. PubMed ID: 1735699
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice.
Iwai H; Matsuno E; Sasai K; Shibamoto Y; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):591-4. PubMed ID: 8005821
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
[TBL] [Abstract][Full Text] [Related]
15. A comparison of tumor and normal tissue levels of acidic, basic and neutral 2-nitroimidazole radiosensitizers in mice.
Minchinton AI; Stratford MR
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1117-20. PubMed ID: 2943710
[TBL] [Abstract][Full Text] [Related]
16. Testing of new hypoxic cell sensitizers in vivo.
Stone HB; Sinesi MS
Radiat Res; 1982 Jul; 91(1):186-98. PubMed ID: 6212963
[No Abstract] [Full Text] [Related]
17. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
Hei TK; Geard CR; Osmak RS; Hall EJ
Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777
[TBL] [Abstract][Full Text] [Related]
18. Fluorinated 2-nitroimidazole derivative hypoxic cell radiosensitizers: radiosensitizing activities and pharmacokinetics.
Sasai K; Iwai H; Yoshizawa T; Nishimoto S; Shibamoto Y; Oya N; Shibata T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):579-82. PubMed ID: 8005818
[TBL] [Abstract][Full Text] [Related]
19. Behavioural and ultrastructural studies of desmethylmisonidazole-induced neurotoxicity in mice.
Chao CF; Subjeck JR; Johnson RJ
Br J Radiol; 1983 Jan; 56(661):27-31. PubMed ID: 6821740
[TBL] [Abstract][Full Text] [Related]
20. Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice.
Cole S; Stratford IJ; Bowler J; Nolan J; Wright EG; Lorimore SA; Adams GE
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):387-95. PubMed ID: 2061115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
